US Backs Oral COVID-19 Therapies And ‘Next Pandemic’ Drug Discovery With $3.2bn
Aims To De-Risk Pandemic R&D
Aiming to mimic public-private COVID-19 vaccine success, the US NIH will fund pandemic drug research, including taking candidates up to Phase II.